This transgene consists of the human nestin second intron enhancer joined to a basic thymidine kinase promoter and the human PDGFB cDNA (without the 5' and 3' untranslated regions) followed by an internal ribosomal entry site (IRES) and a lacZ reporter gene. The minimal nestin enhancer element is specific for embryonic expression but will not drive adult expression of PDGF-B. Three lines were made: 310, 312, and 319. Beta-galactosidase assays show that the transgene is expressed in the developing CNS, with high expression at E10.5, limited expression at E17.5 and no expression at P0. In the retina, transgene expression commences on E17.5 and attains maximal level between P1 and P15, before declining on P20. (J:165035, J:189829)

Basic Information

Allele
Strain of Origin
Allele Type
Mutation
Inheritance
Gene Expression
Related Disease
Reference
(C57BL/6 x CBA)F1
--
Insertion
--
1
--
2

Phenotypes

Legend:
hm: homozygous
ht: heterozygous
cn: conditional genotype
cx: complex: > 1 genome feature
tg: involves transgenes
ot: other: hemizygous, indeterminate,...
(F): Female
(M): Male
phenotype observed
N: normal phenotype
(#): related diseases count
Phenotypes:
Show/Hide columns
Phenotypes

References Literature

Title
PMID
Journal
Year
IF
No Data Found!
Wechat
Comparison
Al agent
Tutorials
Back to top